Stay updated on Entinostat + Pembrolizumab in Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The study record now presents detailed information about the entinostat and pembrolizumab lymphoma trial, including its design, participant criteria, treatment arms, outcomes, and locations. It also shows the study as active but not recruiting.
    Difference
    50%
    Check dated 2026-11-08T10:39:43.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T12:02:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A notice appears announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It is shown above the study page’s 403 error.
    Difference
    1%
    Check dated 2026-10-25T12:19:45.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T11:42:07.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T13:50:57.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study content with a generic error page. This indicates that access to the NCT03179930 study record is blocked, with the error text visible on the page.
    Difference
    18%
    Check dated 2026-09-20T15:46:12.000Z thumbnail image

Stay in the know with updates to Entinostat + Pembrolizumab in Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.